171 related articles for article (PubMed ID: 10630973)
1. Tumor control probability model for alpha-particle-emitting radionuclides.
Roeske JC; Stinchcomb TG
Radiat Res; 2000 Jan; 153(1):16-22. PubMed ID: 10630973
[TBL] [Abstract][Full Text] [Related]
2. The average number of alpha-particle hits to the cell nucleus required to eradicate a tumour cell population.
Roeske JC; Stinchcomb TG
Phys Med Biol; 2006 May; 51(9):N179-86. PubMed ID: 16625028
[TBL] [Abstract][Full Text] [Related]
3. Values of "S," , and <(z1)2> for dosimetry using alpha-particle emitters.
Stinchcomb TG; Roeske JC
Med Phys; 1999 Sep; 26(9):1960-71. PubMed ID: 10505886
[TBL] [Abstract][Full Text] [Related]
4. Relationships between cell survival and specific energy spectra for therapeutic alpha-particle emitters.
Roeske JC; Stinchcomb TG
Radiat Res; 1996 Mar; 145(3):268-73. PubMed ID: 8927693
[TBL] [Abstract][Full Text] [Related]
5. Binary methods for the microdosimetric analysis of cell survival data from alpha-particle irradiation.
Stinchcomb TG; Soyland C; Hassfjell SP; Westman J; Wang SJ; Whitlock JL; Reba RC; Rotmensch J; Roeske JC
Cancer Biother Radiopharm; 2003 Jun; 18(3):481-7. PubMed ID: 12954136
[TBL] [Abstract][Full Text] [Related]
6. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric framework for therapeutic alpha-particle emitters.
Roeske JC; Stinchcomb TG
J Nucl Med; 1997 Dec; 38(12):1923-9. PubMed ID: 9430471
[TBL] [Abstract][Full Text] [Related]
8. Alpha-particle Monte Carlo simulation for microdosimetric calculations using a commercial spreadsheet.
Roeske JC; Hoggarth M
Phys Med Biol; 2007 Apr; 52(7):1909-22. PubMed ID: 17374919
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy with alpha-particle emitters: microdosimetry of cells with a heterogeneous antigen expression and with various diameters of cells and nuclei.
Kvinnsland Y; Stokke T; Aurlien E
Radiat Res; 2001 Feb; 155(2):288-96. PubMed ID: 11175663
[TBL] [Abstract][Full Text] [Related]
10. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
Lee D; Li M; Bednarz B; Schultz MK
Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
[TBL] [Abstract][Full Text] [Related]
11. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides.
Goddu SM; Rao DV; Howell RW
J Nucl Med; 1994 Mar; 35(3):521-30. PubMed ID: 8113908
[TBL] [Abstract][Full Text] [Related]
12. Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. II. Application of the microdosimetric model to experimental results.
Chouin N; Bernardeau K; Bardiès M; Faivre-Chauvet A; Bourgeois M; Apostolidis C; Morgenstern A; Lisbona A; Chérel M; Davodeau F
Radiat Res; 2009 Jun; 171(6):664-73. PubMed ID: 19580473
[TBL] [Abstract][Full Text] [Related]
13. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
[TBL] [Abstract][Full Text] [Related]
14. Simulation of binary methods for the microdosimetric analysis of cell survival after alpha-particle irradiation: ability to distinguish between different models.
Stinchcomb TG; Wang SJ; Roeske JC
Radiat Res; 2004 Nov; 162(5):585-91. PubMed ID: 15624314
[TBL] [Abstract][Full Text] [Related]
15. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
[TBL] [Abstract][Full Text] [Related]
16. A model of cell inactivation by alpha-particle internal emitters.
Humm JL; Chin LM
Radiat Res; 1993 May; 134(2):143-50. PubMed ID: 8488249
[TBL] [Abstract][Full Text] [Related]
17. Alpha-particle microdosimetry.
Chouin N; Bardies M
Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
[TBL] [Abstract][Full Text] [Related]
18. Cell survival fraction estimation based on the probability densities of domain and cell nucleus specific energies using improved microdosimetric kinetic models.
Sato T; Furusawa Y
Radiat Res; 2012 Oct; 178(4):341-56. PubMed ID: 22880622
[TBL] [Abstract][Full Text] [Related]
19. The use of microdosimetric moments in evaluating cell survival for therapeutic alpha-particle emitters.
Roeske JC; Stinchcomb TG
Radiat Res; 1999 Jan; 151(1):31-8. PubMed ID: 9973081
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
